A., Sherr, A., Shirin, S., Solodkina, G., Tapia, E
The 48h symbol next to a product means that the product is only available for RM48 shipping and comes from our partner warehouse
There were significant reductions in HDL cholesterol and TG concentration after weight loss in both groups but no statistical difference in these variables after fasting between the two groups
Development Stage: The drug is moving into Phase 3 trials (ENLIGHTEN-1) as of early 2026 Ongoing Studies: Beyond weight loss, studies are investigating its use for obesity-related conditions such as obstructive sleep apnea (ENLIGHTEN-3) and knee osteoarthritis
GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW, 12 , Doc09
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk